EUVIMEDObjevte EUVIMED
Crossref

Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway

Wanli Xue, Rui Sun, Zheng Hao, Zhenzhen Xing, Hongjie Cheng, Lei Shao

Chemical Biology & Drug Design · 2023

DOI: 10.1111/cbdd.14202 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2023. Written by Wanli Xue and 5 co-authors. Institution: Department of General Surgery, Jiaozuo Hospital of Traditional Chinese Medicine, Jiaozuo, China. Major MEDLINE topics: Proto-Oncogene Proteins c-akt, Stomach Neoplasms. Cited 9 times so far (Crossref); 42 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Tetrandrine (Tet), a traditional Chinese herbal medicine extract, exhibits anti‐cancer effect on many types of cancer. Nonetheless, the action mechanism of Tet in gastric cancer (GC) is still largely unclear. In the current study, proliferation, invasion, and migration of the BGC‐823 and MKN‐45 cells were effectively suppressed by Tet treatment in a dose‐dependent manner. Moreover, Tet suppressed expression of the proliferation‐associated protein PCNA, the interstitial cell phenotype N‐cadherin, and the extracellular matrix‐associated MMP‐2 and MMP‐9 in BGC‐823 and MKN‐45 cells in a dose‐dependent manner. PI3K/AKT/mTOR, a cancer promoting signaling, was inactivated by Tet in a dose‐dependent manner in BGC‐823 and MKN‐45 cells. Furthermore, our results demonstrated that the inhibition of Tet to PCNA, N‐cadherin, MMP‐2, and MMP‐9 expression was partly rescuedby AKT inhibitor or mTOR inhibitor. In animal experiments, tumor growth was inhibited by Tet administration in a dose‐dependent manner. In conclusion, the current data indicated that Tet had a critical effect on inhibiting BGC‐823 and MKN‐45 cells proliferation, migration, invasion, and tumor growth via regulating PI3K/AKT/mTOR signaling pathway, suggesting that Tet might be a potential treatment for GC.

Subjects

MeSH terms (MEDLINE)

Proto-Oncogene Proteins c-aktStomach NeoplasmsAnimalsMatrix Metalloproteinase 9Matrix Metalloproteinase 2Phosphatidylinositol 3-KinasesProliferating Cell Nuclear AntigenCell MovementSignal TransductionTOR Serine-Threonine KinasesCell ProliferationCell Line, TumorBenzylisoquinolines

Author keywords

anti-tumorgastric cancernatural producttetrandrinetraditional Chinese medicine

Substances

Proto-Oncogene Proteins c-aktMatrix Metalloproteinase 9Matrix Metalloproteinase 2Phosphatidylinositol 3-KinasesProliferating Cell Nuclear AntigenTOR Serine-Threonine KinasestetrandrineBenzylisoquinolines

Authors and institutions

  • Department of General Surgery, Jiaozuo Hospital of Traditional Chinese Medicine, Jiaozuo, China.
  • Department of Endocrinology, The People's Hospital of Jiaozuo City, Jiaozuo, China.

Cite

APA

Xue, W., Sun, R., Hao, Z., Xing, Z., Cheng, H., & Shao, L. (2023). Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14202

Vancouver

Xue W, Sun R, Hao Z, Xing Z, Cheng H, Shao L. Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14202

BibTeX
@article{Xue2023,
  author = {Xue, Wanli and Sun, Rui and Hao, Zheng and Xing, Zhenzhen and Cheng, Hongjie and Shao, Lei},
  title = {Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  doi = {10.1111/cbdd.14202}
}
Start for free →